Comparative efficacy and acceptability of novel biologics in the treatment of myasthenia gravis: systematic review and network meta-analysis of randomized trials

Comparative efficacy and acceptability of novel biologics in the treatment of myasthenia gravis: systematic review and network meta-analysis of randomized trials

Abstract Background Myasthenia gravis (MG) is a chronic autoimmune disorder affecting the neuromuscular junction. The emergence of molecular therapies, such as monoclonal antibodies, B-cell-depleting agents, and chimeric antigen receptor T-cell-based therapies, has the potential to transform the tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Chang Guan, Peixi Zhao, Meijin Song, Jing Lu, Huijing Cui, Dongxu Li, Tianying Chang, Yingzi Cui, Xikang Ding, Jian Wang, Peng Xu
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Systematic Reviews
Subjects:
Myasthenia gravis
Novel biologics
Efficacy and acceptability
Network meta-analysis
Online Access:https://doi.org/10.1186/s13643-025-02859-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13643-025-02859-3

Similar Items